GRI Bio executives present at 10th IPF Summit on immune modulation, Phase 2a IPF data
GRI•GRI Bio executives will present at the 10th IPF Summit in Boston from Sept. 29 to Oct. 1, 2026. CEO Marc Hertz is scheduled to discuss Phase 2a development insights for the company’s IPF program.
1. Summit presentations
CSO Vipin Kumar is scheduled to speak Sept. 30 at 2:00 p.m. ET on translational development for IPF therapies. Hertz is scheduled to speak Oct. 1 at 1:30 p.m. ET.
